ARTICLE | Clinical News
NeoRx reports Phase I/II data
July 11, 2000 7:00 AM UTC
NERX reported data from a study of its skeletal targeted radiotherapy (STR) to treat multiple myeloma. Of 56 evaluable patients, 3 maintained complete remission (CR), 20 improved to CR status, 4 had p...